SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001819790-23-000052
Filing Date
2023-06-26
Accepted
2023-06-26 17:45:28
Documents
1
Period of Report
2023-06-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1687815920.html 4  
1 FORM 4 wk-form4_1687815920.xml 4 6471
  Complete submission text file 0001819790-23-000052.txt   7880
Mailing Address C/O GLOBAL BLOOD THERAPEUTICS, INC. 400 EAST JAMIE COURT SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address
Morrison Scott W (Reporting) CIK: 0001662426 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39614 | Film No.: 231043431

Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Issuer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)